Research progress in downstaging treatment of hepatocellular carcinoma before liver transplantation
10.3760/cma.j.cn113884-20200708-00362
- VernacularTitle:肝癌肝移植前降期治疗的研究进展
- Author:
Jianjun WANG
;
Chuxing CHAI
;
Shiran SUN
;
Yong TANG
;
Jun XIONG
;
Chidan WAN
- From:
Chinese Journal of Hepatobiliary Surgery
2021;27(4):305-309
- CountryChina
- Language:Chinese
-
Abstract:
Liver transplantation is an effective curative treatment for hepatocellular carcinoma patients. However, most patients lost the change of surgery when diagnosed as hepatocellular carcinoma. Through local or systemic treatment, hepatocellular carcinoma can be treated in a downstaging manner to reduce tumor burden, so that patients who are beyond the transplantation criteria can still be up to the transplantation criteria after treatment, and finally receive liver transplantation. At present, pre-transplant downstaging treatment has been widely accepted. In this review, we summarized the indications, treatment options, treatment endpoints, and treatment outcomes of pre-transplant downstaging treatment.
